Publication | Closed Access
Evidence that ranolazine behaves as a weak β 1 - and β 2 -adrenoceptor antagonist in the rat cardiovascular system
55
Citations
24
References
2001
Year
Molecular PharmacologyMedicineVascular PharmacologyPhysiologyCardiovascular PharmacologyRat Cardiovascular SystemExperimental PharmacologyPharmacotherapyBeta-adrenergic PharmacologyPharmacology-Adrenoceptor AntagonistAlpha-adrenergic PharmacologyWeak β 1
| Year | Citations | |
|---|---|---|
Page 1
Page 1